Lifecore Biomedical, Inc. De annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Lifecore Biomedical, Inc. De Revenue Growth & History (LFCR)
Lifecore Biomedical, Inc. De reported $75.5M in revenue for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | $75.5M | — | — |
| 2025 · May 25 | 2025-05-25 | $128.9M | $606,000 | +0.47% |
| 2024 | 2024-05-26 | $128.3M | $25.0M | +24.20% |
| 2023 | 2023-05-28 | $103.3M | −$8.0M | −7.19% |
| 2022 | 2022-05-29 | $111.3M | $10.4M | +10.31% |
| 2021 | 2021-05-30 | $100.9M | −$59.2M | −36.98% |
| 2020 | 2020-05-31 | $160.1M | −$397.5M | −71.29% |
| 2019 | 2019-05-26 | $557.6M | $33.3M | +6.36% |
| 2018 | 2018-05-27 | $524.2M | $54.5M | +11.59% |
| 2017 | 2017-05-28 | $469.8M | −$7.1M | −1.50% |
| 2016 | 2016-05-29 | $476.9M | −$62.3M | −11.56% |
| 2015 | 2015-05-31 | $539.3M | $62.4M | +13.10% |
| 2014 | 2014-05-25 | $476.8M | $35.1M | +7.95% |
| 2013 | 2013-05-28 | $441.7M | $124.2M | +39.10% |
| 2012 | 2012-05-27 | $317.6M | $40.8M | +14.75% |
| 2011 | 2011-05-29 | $276.7M | $38.5M | +16.16% |
| 2010 | 2010-05-30 | $238.2M | — | — |
Lifecore Biomedical, Inc. De quarterly revenue
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q2.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $34.2M | — | — |
| Q1 2026 | 2026-03-31 | $23.2M | — | — |
| Q4 2025 | 2025-12-31 | −$27.2M | — | — |
| Q3 2025 · Sep 30 | 2025-09-30 | $31.1M | — | — |
| Q4 2025 | 2025-05-25 | $36.4M | −$1.4M | −3.80% |
| Q3 2025 · Feb 23 | 2025-02-23 | $35.2M | −$550,000 | −1.54% |
| Q2 2025 | 2024-11-24 | $32.6M | $2.4M | +8.01% |
| Q1 2025 | 2024-08-25 | $24.7M | $183,000 | +0.75% |
| Q4 2024 | 2024-05-26 | $37.9M | $6.7M | +21.64% |
| Q3 2024 | 2024-02-25 | $35.7M | $9.2M | +34.55% |
| Q2 2024 | 2023-11-26 | $30.1M | $8.3M | +37.90% |
| Q1 2024 | 2023-08-27 | $24.5M | $798,000 | +3.36% |
| Q4 2023 | 2023-05-28 | $31.1M | $3.0M | +10.81% |
| Q3 2023 | 2023-02-26 | $26.5M | −$8.7M | −24.68% |
| Q2 2023 | 2022-11-27 | $21.9M | −$3.7M | −14.60% |
| Q1 2023 | 2022-08-28 | $23.7M | $1.4M | +6.24% |
| Q4 2022 | 2022-05-29 | $28.1M | −$16.8M | −37.42% |
| Q3 2022 | 2022-02-27 | $35.2M | $7.4M | +26.70% |
| Q2 2022 | 2021-11-28 | $25.6M | $1.8M | +7.60% |
| Q1 2022 | 2021-08-29 | $22.3M | −$345,000 | −1.52% |
| Q4 2021 | 2021-05-30 | $44.9M | −$111.2M | −71.23% |
| Q3 2021 | 2021-02-28 | $27.8M | −$125.1M | −81.82% |
| Q2 2021 | 2020-11-29 | $23.8M | −$118.8M | −83.31% |
| Q1 2021 | 2020-08-30 | $22.7M | −$116.0M | −83.65% |
| Q4 2020 | 2020-05-31 | $156.1M | $3.4M | +2.19% |
| Q3 2020 | 2020-02-23 | $152.9M | −$2.6M | −1.69% |
| Q2 2020 | 2019-11-24 | $142.6M | $18.0M | +14.48% |
| Q1 2020 | 2019-08-25 | $138.7M | $14.0M | +11.27% |
| Q4 2019 | 2019-05-26 | $152.8M | $11.7M | +8.30% |
| Q3 2019 | 2019-02-24 | $155.6M | $10.6M | +7.35% |
| Q2 2019 | 2018-11-25 | $124.6M | $2.1M | +1.71% |
| Q1 2019 | 2018-08-26 | $124.7M | $8.9M | +7.68% |
| Q4 2018 | 2018-05-27 | $141.1M | $19.8M | +16.34% |
| Q3 2018 | 2018-02-25 | $144.9M | $15.6M | +12.08% |
| Q2 2018 | 2017-11-26 | $122.5M | $12.3M | +11.16% |
| Q1 2018 | 2017-08-27 | $115.8M | $6.7M | +6.17% |
| Q4 2017 | 2017-05-28 | $121.3M | −$14.0M | −10.38% |
| Q3 2017 | 2017-02-26 | $129.3M | −$698,000 | −0.54% |
| Q2 2017 | 2016-11-27 | $110.2M | −$30.3M | −21.56% |
| Q1 2017 | 2016-08-28 | $109.1M | −$26.3M | −19.43% |
| Q4 2016 | 2016-05-29 | $135.3M | $865,000 | +0.64% |
| Q3 2016 | 2016-02-28 | $130.0M | −$8.5M | −6.16% |
| Q2 2016 | 2015-11-29 | $140.4M | $7.8M | +5.86% |
| Q1 2016 | 2015-08-30 | $135.4M | $1.7M | +1.30% |
| Q4 2015 | 2015-05-31 | $134.4M | $13.5M | +11.18% |
| Q3 2015 | 2015-03-01 | $138.5M | $12.2M | +9.61% |
| Q2 2015 | 2014-11-30 | $132.7M | $12.6M | +10.53% |
| Q1 2015 | 2014-08-31 | $133.6M | $24.1M | +22.05% |
| Q4 2014 | 2014-05-25 | $120.9M | $13.8M | +12.90% |
| Q3 2014 | 2014-02-23 | $126.4M | $8.5M | +7.22% |
| Q2 2014 | 2013-11-24 | $120.0M | $5.4M | +4.69% |
| Q1 2014 | 2013-08-25 | $109.5M | $7.4M | +7.25% |
| Q2 2013 · May 26 | 2013-05-26 | $107.1M | $24.5M | +29.65% |
| Q3 2013 | 2013-02-24 | $117.9M | $37.8M | +47.22% |
| Q2 2013 · Nov 25 | 2012-11-25 | $114.7M | $33.1M | +40.56% |
| Q1 2013 | 2012-08-26 | $102.1M | $28.8M | +39.25% |
| Q4 2012 | 2012-05-27 | $82.6M | $14.5M | +21.32% |
| Q3 2012 | 2012-02-26 | $80.1M | $6.6M | +8.92% |
| Q2 2012 | 2011-11-27 | $81.6M | $11.4M | +16.25% |
| Q1 2012 | 2011-08-28 | $73.3M | $8.3M | +12.85% |
| Q4 2011 | 2011-05-29 | $68.1M | — | — |
| Q3 2011 | 2011-02-27 | $73.5M | — | — |
| Q2 2011 | 2010-11-28 | $70.2M | — | — |
| Q1 2011 | 2010-08-29 | $65.0M | — | — |
Lifecore Biomedical, Inc. De revenue growth trends
Lifecore Biomedical, Inc. De's latest reported quarter, Q2 2026, generated $34.2M in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Lifecore Biomedical, Inc. De source filings ↗Community posts
Webster agrees Lifecore buyout with cash and contingent payments
Lifecore Biomedical ($LFCR) has agreed to be acquired by a Webster Equity Partners affiliate. Common shareholders would receive $6.28 in cash per share at closing, a 49.5% premium to the preceding trading day’s close, plus a non-tradable co ...
